A-1154 becomes Alcor’s 149th Patient on October 2, 2016

Scott Toth, A-1154, a non-confidential neurocryopreservation member, was pronounced on October 4, 2016 in Florida, USA. Scott became Alcor’s 149th patient on October 6, 2016.

Because he was found after clinical death and because he was a Medical Examiner’s case, no cryoprotection was possible. Fortunately, no autopsy was performed. With an unusually large storm expected to hit the area in the very near future, we raced against time to get Scott out of Florida and to Alcor before flights were grounded. We received Scott early in the evening of October 6. Temperature readings indicated that he was still cooling down to dry ice temperature. On October 7, neuroseparation was completed and cooldown to long-term storage temperature initiated. Cooling to -196 degC was completed on October 12.

Alcor Welcomes Michael Anzis to the Board of Directors

We are glad to announce that at the January 14, 2017 Alcor Board meeting, Michael Anzis was invited to join the Alcor Board of Directors. This fills in the last open position on Alcor’s 9-person board. You can find a short bio on the Directors page.

Link Roundup 1/6

Wait But Why, April 2016, “Why Cryonics Makes Sense” – This is probably now the most read piece in history about the pros and cons of cryonics. It was republished with permission in our magazine. Eight months later, our website still gets decent traffic from this article, and no link roundup would be complete without it. If you’re looking for one article to share with a friend who hasn’t thought about the issue, this is it.

The Economist, February 6, 2016, “Wait Not In Vain” – An excellent piece about the developing business of organ banking. The potential XPRIZE award is currently available to be voted on.

Scientific American, February 1, 2016, “Can Our Minds Live Forever?” – This is a change for Shermer, who wrote a 2001 editorial in Scientific American titled “Nano Nonsense and Cryonics“.

MIT Technology Review, October 19, 2015, “The Science Surrounding Cryonics” – If you haven’t already seen the study from a year ago involving memory retention in cryopreserved roundworms, you should. This article links to that study as part of a longer discussion about cryonics and consciousness.

The Journal of Medical Ethics, February 25, 2015, “The case for cryonics” – I hate linking to articles behind a paywall, but if you’re looking for a thorough treatment of this topic, here it is.

Journal of Critical Care, December 2014, “The Future of Death” – An excellent piece on the changing nature of the boundary between life and death. “If future technologies come to include nanotechnological interventions to enter cells and reverse structural and molecular changes that prevent natural return to normal cell function, then even neuronal cell death as currently understood is not a loss of the capacity to return to consciousness. Whether a patient is living or dead depends on time, place, and circumstances as much as it does on biology.”

Alcor Welcomes Two New Directors and Six New Advisors

When we put out a call in mid-October for potential new Directors and Advisors, we were not expecting such a strong response. A good number of intelligent, talented, and experienced individuals stepped forth.

We are glad to announce that at the December 17, 2016 Alcor Board meeting, two individuals were invited to join the Alcor Board of Directors, and six individuals were invited to join the Advisors to the Board. This expands the Alcor Board from six to eight persons, leaving open one place. Welcome to Michael O’Neal, PhD and Andy Aymeloglu, who we believe will add tremendous value to the Board.

Welcome also to six new Advisors to the Board: Michael Anzis, Linda Chamberlain, David Kremelberg, PhD, James Miller, PhD. JD, James Ryley, PhD, and Robert Wilkes, PhD. Review of respondents is still underway, so additional Advisors may be appointed on a rolling basis.

Shortly after this announcement, the Board and Advisors pages will be updated, including short bios of the new directors.

A-1175 becomes Alcor’s 148th Patient on August 26, 2016

Member A-1175, a neurocryopreservation member of many years standing, was found clinically dead on August 19, 2016. On Friday, August 26, 2016, he arrived at Alcor on dry ice and became Alcor’s 148th patient at the age of 68.

The A-1175 full case report has been published and is available from Cases: http://alcor.org/cases.html

Alcor Northern California Meeting

WHEN: October 23rd, 4:00 pm

WHERE: Cypress Point Lakes Condominium Complex
505 Cypress Point Dr., Mountain View, CA

HOST: Mark Galeck – phone 650-772-1251

Please bring food, we always have a potluck at the meetings. You can also bring a swimsuit and towel, there is sauna here and hot-tub. It takes a while to get the heat going in the clubhouse, so if it is cold outside, it will be cold inside for a little while – so bring some warm clothing.

SuperD dewar arrived today

The SuperD (or Superdewar), designed by Steve Graber, was delivered today. We expect this to house between 9 and 11 Whole Body Patients with much lower per-patient boil off than our existing Bigfoot model.
20160930_123447_sm

Case report for A-2889, Mark Lee Miller, published

New case report published on a case that occurred at the very end of 2015. Full report A-2889 Case Report.

Cryopreservation Minimums Unchanged

At the 2016 Annual Meeting, cryopreservation minimums were left unchanged, remaining at the levels set in 2011. These minimums remain:

Neuro: $80,000 (or $100,000 to receive a waiver of the $180/year Comprehensive Member Standby fee).
Whole Body: $200,000 (or $220,000 to receive a waiver of the $180/year CMS fee).

Look for an article in Cryonics magazine in the near future on likely trends in cryopreservation minimums in the near future and in the longer term.

Massive Dues Reduction for Members of 40+ Years

In recent years, Alcor has introduced discounts in membership dues for long-term members. Effective immediately, a new dues discount has been introduced. Anyone who has been a member for 40 years or longer will have their dues reduced to $60 per year ($15/quarter). This is around 11% of the current full rate for a first family member. This proposal, made by the president and passed unanimously by the board, is intended to build on previous discounts for long-term members and to reassure loyal members that their financial burden will fall over time.